We provide 1 form of BYL-719
BYL-719
1217486-61-7
|
441.47
|
2.129
BYL-719 is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potent antitumor activity. It is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer.
BYL-719 | NVP-BYL-719 | alpelisib
BYL-719 is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potent antitumor activity. It is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer.
BYL-719 | NVP-BYL-719 | alpelisib
$55/5 mg
(EBC)
1
We provide 0 compound for BYL-719